Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate

Aims: One of the major factors in sudden cardiac arrest is the initiation and continuation of deadly arrhythmias during ischemia. It is known that beta-hydroxy-beta-methylbutyrate (HMB) has useful effects such as anti-inflammatory and anti-apoptosis effects in the skeletal muscles. The aim of this s...

Full description

Bibliographic Details
Main Authors: N. Ravanbakhsh, N. Torabi, M. Foadoddini
Format: Article
Language:English
Published: Gonabad University of Medical Sciences (GMU) 2016-09-01
Series:Ufuq-i Dānish
Subjects:
Online Access:http://hms.gmu.ac.ir/article-1-2333-en.pdf
id doaj-3c6a2851988740aab0df902facfaf51f
record_format Article
spelling doaj-3c6a2851988740aab0df902facfaf51f2020-11-24T23:13:47ZengGonabad University of Medical Sciences (GMU)Ufuq-i Dānish1735-18552252-08052016-09-012203209214Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate N. Ravanbakhsh0 N. Torabi1 M. Foadoddini2 Medical Faculty, Birjand University of Medical Sciences, Birjand, Iran Physiology Department, Medical Faculty, Birjand University of Medical Sciences,Birjand, Iran Atherosclerosis & Coronary Research Center, Birjand University of Medical Sciences, Birjand, Ira , foadmohsen@yahoo.comAims: One of the major factors in sudden cardiac arrest is the initiation and continuation of deadly arrhythmias during ischemia. It is known that beta-hydroxy-beta-methylbutyrate (HMB) has useful effects such as anti-inflammatory and anti-apoptosis effects in the skeletal muscles. The aim of this study was to investigate the preventive effects of HMB on the ventricular arrhythmias due to the ischemia. Materials & Methods: In the experimental study, 30 Wistar male rats were randomly divided into three groups including control, HMB320, and HMB700. As control group received normal saline, HMB320 and HMB700 groups orally received 320 and 700 mg/Kg HMB as gavage for 2 weeks, respectively. The rats, having been anesthetized, underwent 30-minute ischemia. Then, the numbers of premature ventricular contractions (PVC), the appearance duration of ventricular tachycardia (VT), and the ventricular fibrillation (VF) were assessed. Data was analyzed by SPSS 16 software using Kruskal-Walis, one-way ANOVA, Tukey’s post-hoc, and Chi-square tests. Findings: There was a significant reduction in the mean PVC number in HMB320 and HMB700 groups than control group (p=0.001). In addition, there was such a significant difference between the groups received the doses (p=0.008). There was a reduction in the mean appearance duration of VT in HMB320 and HMB700 groups than control group (p=0.001). There was a significant reduction in the mean appearance duration of VF in HMB700 group compared to control group, only (p=0.003). Conclusion: Through arrhythmias reduction, 2-week preventive consumption of HMB might considerably reduce the severe side effects of ischemia. http://hms.gmu.ac.ir/article-1-2333-en.pdfBeta-hydroxy-beta-methylbutyrate [http://www.ncbi.nlm.nih.gov/mesh/68014631]Myocardial Ischemia [http://www.ncbi.nlm.nih.gov/mesh/68017202]Arrhythmias [http://www.ncbi.nlm.nih.gov/mesh/68001145]
collection DOAJ
language English
format Article
sources DOAJ
author N. Ravanbakhsh
N. Torabi
M. Foadoddini
spellingShingle N. Ravanbakhsh
N. Torabi
M. Foadoddini
Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
Ufuq-i Dānish
Beta-hydroxy-beta-methylbutyrate [http://www.ncbi.nlm.nih.gov/mesh/68014631]
Myocardial Ischemia [http://www.ncbi.nlm.nih.gov/mesh/68017202]
Arrhythmias [http://www.ncbi.nlm.nih.gov/mesh/68001145]
author_facet N. Ravanbakhsh
N. Torabi
M. Foadoddini
author_sort N. Ravanbakhsh
title Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
title_short Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
title_full Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
title_fullStr Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
title_full_unstemmed Preventive Effects of Beta-Hydroxy-Beta-Methyl Butyrate
title_sort preventive effects of beta-hydroxy-beta-methyl butyrate
publisher Gonabad University of Medical Sciences (GMU)
series Ufuq-i Dānish
issn 1735-1855
2252-0805
publishDate 2016-09-01
description Aims: One of the major factors in sudden cardiac arrest is the initiation and continuation of deadly arrhythmias during ischemia. It is known that beta-hydroxy-beta-methylbutyrate (HMB) has useful effects such as anti-inflammatory and anti-apoptosis effects in the skeletal muscles. The aim of this study was to investigate the preventive effects of HMB on the ventricular arrhythmias due to the ischemia. Materials & Methods: In the experimental study, 30 Wistar male rats were randomly divided into three groups including control, HMB320, and HMB700. As control group received normal saline, HMB320 and HMB700 groups orally received 320 and 700 mg/Kg HMB as gavage for 2 weeks, respectively. The rats, having been anesthetized, underwent 30-minute ischemia. Then, the numbers of premature ventricular contractions (PVC), the appearance duration of ventricular tachycardia (VT), and the ventricular fibrillation (VF) were assessed. Data was analyzed by SPSS 16 software using Kruskal-Walis, one-way ANOVA, Tukey’s post-hoc, and Chi-square tests. Findings: There was a significant reduction in the mean PVC number in HMB320 and HMB700 groups than control group (p=0.001). In addition, there was such a significant difference between the groups received the doses (p=0.008). There was a reduction in the mean appearance duration of VT in HMB320 and HMB700 groups than control group (p=0.001). There was a significant reduction in the mean appearance duration of VF in HMB700 group compared to control group, only (p=0.003). Conclusion: Through arrhythmias reduction, 2-week preventive consumption of HMB might considerably reduce the severe side effects of ischemia.
topic Beta-hydroxy-beta-methylbutyrate [http://www.ncbi.nlm.nih.gov/mesh/68014631]
Myocardial Ischemia [http://www.ncbi.nlm.nih.gov/mesh/68017202]
Arrhythmias [http://www.ncbi.nlm.nih.gov/mesh/68001145]
url http://hms.gmu.ac.ir/article-1-2333-en.pdf
work_keys_str_mv AT nravanbakhsh preventiveeffectsofbetahydroxybetamethylbutyrate
AT ntorabi preventiveeffectsofbetahydroxybetamethylbutyrate
AT mfoadoddini preventiveeffectsofbetahydroxybetamethylbutyrate
_version_ 1725596671710068736